Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
- PMID: 33388793
- PMCID: PMC7778474
- DOI: 10.1007/s00134-020-06330-w
Ten reasons why corticosteroid therapy reduces mortality in severe COVID-19
Conflict of interest statement
The authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply.Intensive Care Med. 2021 Mar;47(3):357-358. doi: 10.1007/s00134-020-06335-5. Epub 2021 Jan 28. Intensive Care Med. 2021. PMID: 33507321 Free PMC article. No abstract available.
Comment on
-
The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19.Intensive Care Med. 2020 Nov;46(11):2067-2070. doi: 10.1007/s00134-020-06223-y. Epub 2020 Oct 7. Intensive Care Med. 2020. PMID: 33026460 Free PMC article. No abstract available.
References
-
- RECOVERY Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. - DOI - PMC - PubMed
-
- WHO React Working Group. Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB, Dequin PF, Du B, Emberson J, Fisher D, Giraudeau B, Gordon AC, Granholm A, Green C, Haynes R, Heming N, Higgins JPT, Horby P, Juni P, Landray MJ, Le Gouge A, Leclerc M, Lim WS, Machado FR, McArthur C, Meziani F, Moller MH, Perner A, Petersen MW, Savovic J, Tomazini B, Veiga VC, Webb S, Marshall JC. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324:1330–1341. doi: 10.1001/jama.2020.17023. - DOI - PMC - PubMed
-
- Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, Martín-Rodríguez C, Díaz-Domínguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Añón JM, Fernández RL, González-Martín JM, Dexamethasone in ARDS network Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
